What Is Leucovorin?
Leucovorin is a prescription-strength form of folate — the active, bioavailable version the brain can use directly. Unlike the folic acid found in vitamins and fortified foods, leucovorin (also called folinic acid) bypasses several steps in the body's folate processing pathway, delivering folate where the brain needs it without depending on the body's ability to convert it first.
Leucovorin has been used in medicine for decades — most commonly to offset certain chemotherapy side effects. Its application in psychiatry is newer and still evolving, but the research behind it is grounded in a well-understood biological mechanism.
Why Does Folate Matter for Mental Health?
Folate is essential for producing neurotransmitters — the chemical messengers that regulate mood, focus, motivation, and stress response. When folate metabolism is impaired, the brain may struggle to make adequate levels of serotonin, dopamine, and norepinephrine, even when someone is taking antidepressants designed to support those same systems.
This is one reason some people don't respond fully to standard psychiatric medications: the medications may be doing their job, but impaired folate metabolism limits how much benefit is possible.
The MTHFR Connection
One of the most common genetic reasons for folate processing problems is a variant in a gene called MTHFR (methylenetetrahydrofolate reductase). Roughly 40 to 60 percent of the general population carries at least one copy of a common MTHFR variant, and in people with depression or anxiety, that number may be higher.
If you carry an MTHFR variant, your body converts folate less efficiently — meaning you may have adequate dietary intake but still end up with functionally low folate activity in the brain. Leucovorin bypasses the step MTHFR is responsible for, and unlike standard folic acid, the active form — whether leucovorin or L-methylfolate — can actually make a difference for this group.
Who Might Benefit From Leucovorin in Psychiatry?
Leucovorin isn't a first-line treatment for everyone, and it isn't a replacement for established therapies. But there is a growing body of research supporting its use as an augmentation strategy — meaning it's added alongside existing treatment to enhance the overall response — in specific populations:
People with Treatment-Resistant Depression
Studies have found that adding leucovorin to antidepressant therapy can meaningfully improve outcomes for patients who haven't responded adequately to one or more medications. Because folate deficiency can blunt the effectiveness of antidepressants, correcting that deficiency can make an existing medication work noticeably better.
Individuals with MTHFR Variants
For anyone who has had MTHFR testing — whether through a primary care provider, a direct-to-consumer genetic test, or psychiatric workup — a functional folate deficiency may be part of the picture. Leucovorin is one way to address it directly.
People with Schizophrenia
Some of the most compelling research on leucovorin in psychiatry involves schizophrenia. Several clinical trials, including double-blind randomized controlled studies, have found that leucovorin augmentation can reduce negative symptoms — things like emotional blunting, social withdrawal, and reduced motivation — that are notoriously difficult to treat with antipsychotic medications alone. Low folate levels are associated with more severe symptoms and poorer cognitive outcomes in schizophrenia. That makes folate supplementation a logical, relatively low-risk intervention to explore.
Some Children with Autism Spectrum Disorder
One of the more hopeful areas of leucovorin research involves a specific subset of children with autism spectrum disorder (ASD). It has shown meaningful benefit in children whose brains aren't getting enough folate due to a biological mechanism called cerebral folate deficiency — often driven by folate receptor autoantibodies (FRAAs).
Some children with ASD develop antibodies that block folate from crossing into the brain. Even with adequate folate in the bloodstream, the brain is functionally cut off — and since folate is critical to brain development and function, this can contribute to the communication and behavioral challenges associated with autism.
Leucovorin bypasses the blocked receptor pathway and enters the brain through a different route, restoring access to the folate it's been missing. A landmark double-blind, placebo-controlled study published in Molecular Psychiatry found that children with ASD who tested positive for FRAAs and were treated with leucovorin showed significant improvements in language, verbal communication, attention, and social awareness compared to placebo. Children with the highest FRAA levels tended to show the greatest response.
This is still an emerging, investigational area — not yet a standard of care for ASD. Leucovorin here is a targeted intervention for a specific biological finding, not a treatment for autism broadly. FRAA testing and close partnership with a qualified provider are essential before considering this approach. For families who have tried many approaches without the results they hoped for, this is an area worth an honest, evidence-based conversation.
Patients with Unexplained Treatment Gaps
If someone's psychiatric treatment “should” be working but isn't — or works partially but plateaus — it's worth asking whether underlying metabolic or nutritional factors are playing a role. Folate status is one of the more actionable pieces of that puzzle.
Is Leucovorin Safe?
Generally, yes. Leucovorin has a well-established safety profile and is well-tolerated by most people. As a folate-based intervention, it doesn't carry the same risks as adding another psychotropic medication. That said, it's still a prescription medication that should be used under the guidance of a qualified provider who understands your full clinical picture — your current medications, labs, and treatment history included.
Getting the Right Evaluation
Not everyone needs leucovorin, and recommending it without a thorough assessment would be doing you a disservice. A good starting point is a comprehensive psychiatric evaluation that includes attention to your treatment history, any genetic factors, and your overall response to current or past medications.
At MindCare Innovations, we take an individualized, whole-person approach to psychiatric care. If there's reason to think something like folate metabolism is affecting your treatment response, that's a conversation worth having. Dr. Clint Nacar, DNP, PMHNP-BC, works with patients across California through secure telehealth visits — treating children, adolescents, and adults with conditions including depression, anxiety, bipolar disorder, ADHD, and schizophrenia. No referral required.
This post is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or supplement.
Dr. Clint Nacar, DNP, PMHNP-BC is a board-certified Psychiatric Mental Health Nurse Practitioner and founder of MindCare Innovations. He provides telehealth psychiatric care for children, adolescents, and adults across California, specializing in ADHD, depression, anxiety, and medication management.